Dashboard
Manage Tickers

MRKMerck & Co., Inc.

NYSE merck.com


$ 128.53 $ -0.44 (-0.34 %)    

Friday, 12-Jul-2024 11:29:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 497.34 $ 5.55 (1.13 %)
DIA $ 400.86 $ 2.02 (0.51 %)
SPY $ 561.58 $ 4.08 (0.73 %)
TLT $ 93.54 $ 0.03 (0.03 %)
GLD $ 222.92 $ 0.89 (0.4 %)
$ 128.97
$ 129.43
$ 128.67 x 100
$ 0.00 x 0
$ 128.31 - $ 129.91
$ 97.23 - $ 134.63
7,052,117
na
326.66B
$ 0.32
$ 141.65
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

australia-based-cancer-focused-immuteps-lead-cancer-drug-shows-meaningful-response-in-untreated-head--neck-cancer-stock-soars
Australia Based Cancer Focused Immutep's L...
07/12/2024 11:39:58

Immutep announces results from Cohort B of the TACTI-003 Phase 2b trial. The combination of eftilagimod alfa and Merck's Ke...

merck-completes-acquisition-of-eyebio-to-record-a-charge-of-13b-or-050-per-share-in-q3-which-will-be-included-in-non-gaap-results
Merck Completes Acquisition Of EyeBio; To ...
07/12/2024 10:47:57

As previously disclosed, this transaction is being accounted for as an asset acquisition. Merck will record a charge of approxi...

beyond-the-numbers-6-analysts-discuss-merck--co-stock
Beyond The Numbers: 6 Analysts Discuss Mer...
07/11/2024 18:00:53

morgan-stanley-maintains-equal-weight-on-merck--co-raises-price-target-to-134
Morgan Stanley Maintains Equal-Weight on M...
07/11/2024 17:11:21

Morgan Stanley analyst Terence Flynn maintains Merck & Co (NYSE:MRK) with a Equal-Weight and raises the price target fro...

merck-animal-health-completes-acquisition-of-elanco-animal-health-assets
Merck Animal Health Completes Acquisition ...
07/09/2024 17:59:08

Merck Animal Health announced the purchase of Elanco Animal Health's aquaculture business.Merck & Company (NYSE:MRK) co...

Core News & Articles
Prelude Therapeutics Collaborates With Mer...
07/09/2024 11:34:54

Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor ...

merck--co-unusual-options-activity
Merck & Co Unusual Options Activity
07/05/2024 17:18:56

roches-new-immunotherapy-fails-to-show-benefit-over-mercks-blockbuster-keytruda-in-lung-cancer-patients
Roche's New Immunotherapy Fails To Show Be...
07/05/2024 12:09:50

Roche's SKYSCRAPER-06 study of tiragolumab plus Tecentriq and chemotherapy did not meet primary endpoints for progression-f...

mrna-technology-promises-to-make-a-long-time-coming-turning-point-in-cancer-treatment
mRNA Technology Promises To Make A Long-Ti...
07/02/2024 17:38:18

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame duri...

insights-into-merck-amp-cos-performance-versus-peers-in-pharmaceuticals-sector
Insights Into Merck & Co's Performance...
07/02/2024 15:00:39

5-biggest-winners-5-biggest-losers-from-dow-jones-industrial-average-in-first-half-2024
5 Biggest Winners, 5 Biggest Losers From D...
07/01/2024 22:38:43

Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best an...

whats-going-on-with-merck-stock-on-monday
What's Going On With Merck Stock On Monday?
07/01/2024 17:26:41

Merck secures exclusive global rights to develop and commercialize opevesostat (MK-5684/ODM-208) for hormone-dependent cancers....

market-whales-and-their-recent-bets-on-mrk-options
Market Whales and Their Recent Bets on MRK...
07/01/2024 15:47:10

merck-and-orion-announce-mutual-exercise-of-option-to-convert-opevesostat-co-commercialization-agreement-into-an-exclusive-global-license-for-merck-orion-now-eligible-for-development-milestones-up-to-30m-regulatory-milestones-up-to-625m-and-sales-milestones-up-to-975m
Merck And Orion Announce Mutual Exercise O...
07/01/2024 12:20:16

whats-going-on-with-merck-stock-on-friday
What's Going On With Merck Stock On Friday?
06/28/2024 12:39:32

The CDC's Advisory Committee on Immunization Practices recommends Merck's Capvaxive for adults 65+ and certain at-risk ...

the-committee-for-medicinal-products-for-human-use-of-the-european-medicines-agency-recommended-the-approval-of-mercks-winrevair-sotatercept-combined-with-other-pulmonary-arterial-hypertension-pah-therapies-for-pah-in-adult-patients
The Committee For Medicinal Products For H...
06/28/2024 11:02:41

, European Commission's Decision Is Expected In Q3 

Core News & Articles
Merck's Pneumonia Shot Recommended For Hea...
06/27/2024 20:54:35

- Bloomberg

a-closer-look-at-merck--cos-options-market-dynamics
A Closer Look at Merck & Co's Options Mark...
06/27/2024 19:49:25

Core News & Articles
CDC's ACIP Unanimously Votes To Add Merck ...
06/27/2024 19:40:39

- Reuters

fda-declines-to-approve-merck-daiichi-sankyo-partnered-lung-cancer-drug
FDA Declines To Approve Merck-Daiichi Sank...
06/27/2024 14:13:16

The FDA issued a Complete Response Letter for Daiichi Sankyo and Merck's BLA for patritumab deruxtecan targeting EGFR-mutat...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)